Statement Of Cash Flows

Medrx Co.,Ltd. - Filing #7269497

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-802,738,000 JPY
-828,621,000 JPY
-933,582,000 JPY
-930,080,000 JPY
Depreciation
38,427,000 JPY
45,565,000 JPY
Increase (decrease) in allowance for doubtful accounts
-2,288,000 JPY
JPY
Interest and dividend income
-225,000 JPY
-10,000 JPY
Decrease (increase) in inventories
60,000 JPY
-1,735,000 JPY
Subtotal
-851,741,000 JPY
-912,882,000 JPY
Income taxes paid
-4,420,000 JPY
-2,961,000 JPY
Other, net
-74,007,000 JPY
5,091,000 JPY
Net cash provided by (used in) operating activities
-803,403,000 JPY
-913,800,000 JPY
Interest and dividends received
225,000 JPY
10,000 JPY
Cash flows from operating activities
Cash flows from operating activities
Increase (decrease) in accounts payable - other
-1,056,000 JPY
-46,970,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-265,000 JPY
-759,000 JPY
Net cash provided by (used in) investing activities
-3,155,000 JPY
-759,000 JPY
Cash flows from facilities maintenance and investing activities
Cash flows from financing activities
Purchase of treasury shares
JPY
0 JPY
Net cash provided by (used in) financing activities
1,066,994,000 JPY
1,639,492,000 JPY
Effect of exchange rate change on cash and cash equivalents
-3,517,000 JPY
1,762,000 JPY
Net increase (decrease) in cash and cash equivalents
256,918,000 JPY
726,694,000 JPY
Cash and cash equivalents
1,977,638,000 JPY
1,720,720,000 JPY
994,025,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.